The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the matter ...
June 11 (Reuters) - Novavax's (NVAX.O), opens new tab experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in adults aged 65 and older, ...
Hosted on MSN
Novavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval Hopes
Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following renewed hopes for a regulatory nod for its COVID-19 vaccine, which has been ...
The President Donald Trump administration’s request for Novavax Inc. (NASDAQ:NVAX) to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and ...
Federal regulators are asking Novavax NVAX17.42%increase; green up pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results